574 related articles for article (PubMed ID: 34414447)
1. Roles of α‑synuclein in gastrointestinal microbiome dysbiosis‑related Parkinson's disease progression (Review).
Lei Q; Wu T; Wu J; Hu X; Guan Y; Wang Y; Yan J; Shi G
Mol Med Rep; 2021 Oct; 24(4):. PubMed ID: 34414447
[TBL] [Abstract][Full Text] [Related]
2. Gut brain axis: an insight into microbiota role in Parkinson's disease.
Moustafa SA; Mohamed S; Dawood A; Azar J; Elmorsy E; Rizk NAM; Salama M
Metab Brain Dis; 2021 Oct; 36(7):1545-1557. PubMed ID: 34370175
[TBL] [Abstract][Full Text] [Related]
3. The MHC class II transactivator modulates seeded alpha-synuclein pathology and dopaminergic neurodegeneration in an in vivo rat model of Parkinson's disease.
Jimenez-Ferrer I; Bäckström F; Dueñas-Rey A; Jewett M; Boza-Serrano A; Luk KC; Deierborg T; Swanberg M
Brain Behav Immun; 2021 Jan; 91():369-382. PubMed ID: 33223048
[TBL] [Abstract][Full Text] [Related]
4. Parkinson's disease-derived α-synuclein assemblies combined with chronic-type inflammatory cues promote a neurotoxic microglial phenotype.
Yildirim-Balatan C; Fenyi A; Besnault P; Gomez L; Sepulveda-Diaz JE; Michel PP; Melki R; Hunot S
J Neuroinflammation; 2024 Feb; 21(1):54. PubMed ID: 38383421
[TBL] [Abstract][Full Text] [Related]
5. Implications of the Gut Microbiome in Parkinson's Disease.
Elfil M; Kamel S; Kandil M; Koo BB; Schaefer SM
Mov Disord; 2020 Jun; 35(6):921-933. PubMed ID: 32092186
[TBL] [Abstract][Full Text] [Related]
6. Galectin-3 shapes toxic alpha-synuclein strains in Parkinson's disease.
García-Revilla J; Boza-Serrano A; Jin Y; Vadukul DM; Soldán-Hidalgo J; Camprubí-Ferrer L; García-Cruzado M; Martinsson I; Klementieva O; Ruiz R; Aprile FA; Deierborg T; Venero JL
Acta Neuropathol; 2023 Jul; 146(1):51-75. PubMed ID: 37202527
[TBL] [Abstract][Full Text] [Related]
7. Microbiota- Brain-Gut-Axis Relevance to Parkinson's Disease: Potential Therapeutic Effects of Probiotics.
Raj K; Singh S; Chib S; Mallan S
Curr Pharm Des; 2022; 28(37):3049-3067. PubMed ID: 36200207
[TBL] [Abstract][Full Text] [Related]
8. Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson's Disease.
Sampson TR; Debelius JW; Thron T; Janssen S; Shastri GG; Ilhan ZE; Challis C; Schretter CE; Rocha S; Gradinaru V; Chesselet MF; Keshavarzian A; Shannon KM; Krajmalnik-Brown R; Wittung-Stafshede P; Knight R; Mazmanian SK
Cell; 2016 Dec; 167(6):1469-1480.e12. PubMed ID: 27912057
[TBL] [Abstract][Full Text] [Related]
9. The link between the gut microbiota and Parkinson's Disease: A systematic mechanism review with focus on α-synuclein transport.
Nielsen SD; Pearson NM; Seidler K
Brain Res; 2021 Oct; 1769():147609. PubMed ID: 34371014
[TBL] [Abstract][Full Text] [Related]
10. Neuropathology of α-synuclein in Parkinson's disease.
Choong CJ; Mochizuki H
Neuropathology; 2022 Apr; 42(2):93-103. PubMed ID: 35362115
[TBL] [Abstract][Full Text] [Related]
11. The Gut-Brain Axis: Two Ways Signaling in Parkinson's Disease.
Dogra N; Mani RJ; Katare DP
Cell Mol Neurobiol; 2022 Mar; 42(2):315-332. PubMed ID: 33649989
[TBL] [Abstract][Full Text] [Related]
12. Fiber deprivation and microbiome-borne curli shift gut bacterial populations and accelerate disease in a mouse model of Parkinson's disease.
Schmit KJ; Garcia P; Sciortino A; Aho VTE; Pardo Rodriguez B; Thomas MH; Gérardy JJ; Bastero Acha I; Halder R; Cialini C; Heurtaux T; Ostahi I; Busi SB; Grandmougin L; Lowndes T; Singh Y; Martens EC; Mittelbronn M; Buttini M; Wilmes P
Cell Rep; 2023 Sep; 42(9):113071. PubMed ID: 37676767
[TBL] [Abstract][Full Text] [Related]
13. Alpha-Synuclein Contribution to Neuronal and Glial Damage in Parkinson's Disease.
Saramowicz K; Siwecka N; Galita G; Kucharska-Lusina A; Rozpędek-Kamińska W; Majsterek I
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203531
[TBL] [Abstract][Full Text] [Related]
14. Altered gut microbiota and intestinal permeability in Parkinson's disease: Pathological highlight to management.
Sharma S; Awasthi A; Singh S
Neurosci Lett; 2019 Nov; 712():134516. PubMed ID: 31560998
[TBL] [Abstract][Full Text] [Related]
15. The regulatory role of α-synuclein and parkin in neuronal cell apoptosis; possible implications for the pathogenesis of Parkinson's disease.
Yasuda T; Mochizuki H
Apoptosis; 2010 Nov; 15(11):1312-21. PubMed ID: 20221696
[TBL] [Abstract][Full Text] [Related]
16. A new model to study cell-to-cell transfer of αSynuclein in vivo.
Mercado G; López N; Martínez A; Sardi SP; Hetz C
Biochem Biophys Res Commun; 2018 Sep; 503(3):1385-1393. PubMed ID: 30025892
[TBL] [Abstract][Full Text] [Related]
17. Aggregation of αSynuclein promotes progressive in vivo neurotoxicity in adult rat dopaminergic neurons.
Taschenberger G; Garrido M; Tereshchenko Y; Bähr M; Zweckstetter M; Kügler S
Acta Neuropathol; 2012 May; 123(5):671-83. PubMed ID: 22167382
[TBL] [Abstract][Full Text] [Related]
18. The Down-Regulation of Clusterin Expression Enhances the αSynuclein Aggregation Process.
Lenzi C; Ramazzina I; Russo I; Filippini A; Bettuzzi S; Rizzi F
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 33003328
[TBL] [Abstract][Full Text] [Related]
19. The Link between Gut Dysbiosis and Neuroinflammation in Parkinson's Disease.
Baizabal-Carvallo JF; Alonso-Juarez M
Neuroscience; 2020 Apr; 432():160-173. PubMed ID: 32112917
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive Review on Potential Signaling Pathways Involving the Transfer of α-Synuclein from the Gut to the Brain That Leads to Parkinson's Disease.
Kumari S; Taliyan R; Dubey SK
ACS Chem Neurosci; 2023 Feb; 14(4):590-602. PubMed ID: 36724408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
